Grape Impact on Human Gut Microbiome
Part of paid clinical trials in New York, New York.
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Study ID
- NCT07797803
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Gut Microbiomes
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Grape Powder — DIETARY_SUPPLEMENT72 g of grape powder for daily consumption for 28 days.
- Placebo Powder — OTHER72 g of matching placebo for daily consumption for 28 days.
Study Details
This is a bio-specimen analysis and dietary intervention study that will examine whether the daily consumption of California table grape powder significantly modulates the gut microbiome and systemic immune profiles in healthy adults. The primary objective is to characterize longitudinal changes in microbial strains, metabolites, and immune markers following a 4-week grape intervention compared to a placebo. Methods include a screening of up to 300 individuals to evaluate pre-specified microbiome eligibility criteria, followed by a randomized, double-blind, placebo-controlled, parallel-group design where up to 40 participants will provide fecal and blood samples for high-resolution metagenomic sequencing and LC-MS/MS metabolomics at baseline, mid-study, and post-washout. Participants who meet the microbiome screening and other study eligibility criteria may be invited to participate in the intervention phase; participation in the screening phase does not guarantee enrollment in the intervention phase.
Key Dates
- First listed
- Sep 1, 2026
- Start date
- Sep 30, 2026
- Status verified
- Aug 2026
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Grape PowderReceive grape powder for consumption during intervention stage.
- Placebo Comparator: ControlReceive placebo control powder for consumption during intervention stage.
Primary Outcome Measure
Long read sequencing [ Time Frame: 3 collections at T0 (after 3 weeks of dietary control), at week 4 (after grape or placebo powder daily), and at week 8 (after 4 weeks of returning back to normal diet) ]
Central Contacts
- Gang Fang, PhD212-659-1570
- Edward A Mead, PhD212-659-6844
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Gang Fang, PhD (PRINCIPAL_INVESTIGATOR) |